Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2550]

FDA approves pralsetinib for lung cancer with RET gene fusions

FDA approves pralsetinib for lung cancer with RET gene fusions

'Social smokers' face disproportionate risk of death from lung disease and lung cancer

'Social smokers' face disproportionate risk of death from lung disease and lung cancer

Moffitt researchers identify metastasis driver in BRAF inhibitor resistant melanoma

Moffitt researchers identify metastasis driver in BRAF inhibitor resistant melanoma

Cancer's ongoing evolution

Cancer's ongoing evolution

Researchers identify RNA molecule that helps lung cancer cells evade immune system

Researchers identify RNA molecule that helps lung cancer cells evade immune system

Lung cancer trial of RET inhibitor selpercatinib achieves durable responses in majority of patients with RET gene fusions

Lung cancer trial of RET inhibitor selpercatinib achieves durable responses in majority of patients with RET gene...

FDA grants priority review to trilaciclib for the treatment of small cell lung cancer

FDA grants priority review to trilaciclib for the treatment of small cell lung cancer

Researchers discover how enzyme protects cells from DNA damage

Researchers discover how enzyme protects cells from DNA damage

Smoking strongly linked to women's lower take up of cancer screening services

Smoking strongly linked to women's lower take up of cancer screening services

IASLC WCLC 2020: CheckMate-743 shows that dual immunotherapy, nivolumab plus ipilimumab improves overall survival for patients with previously untreated mesothelioma

IASLC WCLC 2020: CheckMate-743 shows that dual immunotherapy, nivolumab plus ipilimumab improves overall survival...

More from ecancer